129 related articles for article (PubMed ID: 9802328)
21. Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes.
Nielsen SE; Munch-Petersen B; Mejer J
Leuk Res; 1995 Jul; 19(7):443-7. PubMed ID: 7637389
[TBL] [Abstract][Full Text] [Related]
22. Study of the efficacy of a pronucleotide of 2-chloro-2'-deoxyadenosine in deoxycytidine kinase-deficient lymphoma cells.
Bontemps F; Meier C; Delacauw A; Balzarini J; Galmarini C; van den Neste E
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):997-1000. PubMed ID: 17065053
[TBL] [Abstract][Full Text] [Related]
23. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological basis for cladribine resistance.
Lotfi K; Juliusson G; Albertioni F
Leuk Lymphoma; 2003 Oct; 44(10):1705-12. PubMed ID: 14692522
[TBL] [Abstract][Full Text] [Related]
25. Relationship between cladribine (CdA) plasma, intracellular CdA-5'-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL).
Albertioni F; Lindemalm S; Eriksson S; Juliusson G; Liliemark J
Adv Exp Med Biol; 1998; 431():693-7. PubMed ID: 9598154
[TBL] [Abstract][Full Text] [Related]
26. Distinct inhibitory effects of 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine on DNA methyltransferase in human T-lymphocytes.
Wyczechowska D; Ruckemann K; Duley JA; Simmonds AH; Fabianowska-Majewska K
Nucleosides Nucleotides; 1999; 18(4-5):831-4. PubMed ID: 10432687
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Shewach DS; Hertel LW; Secrist JA; Montgomery JA; Bennett LL
Mol Pharmacol; 1999 Mar; 55(3):515-20. PubMed ID: 10051535
[TBL] [Abstract][Full Text] [Related]
28. Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes.
Van Den Neste E; Smal C; Cardoen S; Delacauw A; Frankard J; Ferrant A; Van den Berghe G; Bontemps F
Biochem Pharmacol; 2003 Feb; 65(4):573-80. PubMed ID: 12566084
[TBL] [Abstract][Full Text] [Related]
29. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
30. Effects of 2-chloro-2'-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line.
Cardoen S; Van den Neste E; Smal C; Rosier JF; Ferrant A; Van den Berghe G; Bontemps F
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1425-9. PubMed ID: 15571271
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory Effects Associated with Cladribine Treatment.
Fissolo N; Calvo-Barreiro L; Eixarch H; Boschert U; Espejo C; Montalban X; Comabella M
Cells; 2021 Dec; 10(12):. PubMed ID: 34943995
[TBL] [Abstract][Full Text] [Related]
32. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.
Han T; Fernandez M; Chou TC; Agarwal RP
J Cancer Res Clin Oncol; 2005 Sep; 131(9):609-16. PubMed ID: 16044347
[TBL] [Abstract][Full Text] [Related]
34. Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a phase I pharmacologically directed dose-escalation concept for 2-chloro-2'-deoxyadenosine.
Reichelová V; Juliusson G; Spasokoukotskaja T; Eriksson S; Liliemark J
Cancer Chemother Pharmacol; 1995; 36(6):524-9. PubMed ID: 7554045
[TBL] [Abstract][Full Text] [Related]
35. A crucial role for ATR in the regulation of deoxycytidine kinase activity.
Beyaert M; Starczewska E; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2016 Jan; 100():40-50. PubMed ID: 26620371
[TBL] [Abstract][Full Text] [Related]
36. Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status.
Carlini F; Ivaldi F; Gualandi F; Boschert U; Centonze D; Matarese G; Salvetti M; Kerlero de Rosbo N; Uccelli A
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):195-205. PubMed ID: 33851318
[TBL] [Abstract][Full Text] [Related]
37. Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
Laugel B; Borlat F; Galibert L; Vicari A; Weissert R; Chvatchko Y; Bruniquel D
J Neuroimmunol; 2011 Dec; 240-241():52-7. PubMed ID: 22035961
[TBL] [Abstract][Full Text] [Related]
38. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Zhang Y; Secrist JA; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
[TBL] [Abstract][Full Text] [Related]
39. Reversible permeabilization of lymphocytes destroys the incorporation of deoxythymidine but not of deoxycytidine.
Taljanidisz J; Sasvari-Szekely M; Spasokutotskaja T; Antoni F; Staub M
Biochim Biophys Acta; 1986 Mar; 885(3):266-71. PubMed ID: 3947681
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of deoxycytidine kinase results in prolonged maintenance of the enzyme activity.
Keszler G; Spasokoukotskaja T; Virga S; Sasvari-Szekely M; Staub M
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1357-61. PubMed ID: 15571258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
